Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS-3020 Category:

OVERVIEW

Amid the COVID-19 pandemic, the Injectable Drug Delivery Market is expected to grow at a CAGR of 13.4% during the forecast period 2021-2026. The increasing prevalence of chronic diseases, rising aging population, increasing use of biologics is analyzed to drive the market growth. Moreover, the growing occurrence of needlestick injuries, and the benefits of injections is also propelling the growth of market. The report will also account for COVID-19 as a key market contributor.

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 1

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 2

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 3

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 4

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 5

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 6

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 7

Injectable Drug Delivery Market by Administration (Musculoskeletal, Skin), Type (Formulation, Device), Therapeutic (Cancer), Usage Pattern (Immunization), Patient Care Setting (Hospital, Home Care), Distribution Channel (Hospital) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Injectable Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Injectable Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Injectable Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Injectable Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Injectable Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Injectable Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Injectable Drug Delivery Market – By Type (Market Size – & million/billion)
8.1 Device
8.2 Formulations

9 Global Injectable Drug Delivery Market – By Packaging
9.1 Cartridges
9.2 Bottles
9.3 Vials
9.4 Ampules

10 Global Injectable Drug Delivery Market – By Therapeutic Application
10.1 Autoimmune Diseases
10.2 Orphan Diseases
10.3 Hormonal Disorders
10.4 Cancer
10.5 Others

11 Global Injectable Drug Delivery Market – By Application
11.1 Respiratory diseases
11.2 Diabetes
11.3 Hormones replacement
11.4 Neurology addiction
11.5 Cardiovascular diseases
11.6 Others

12 Global Injectable Drug Delivery Market – By Distribution Channel
12.1 Hospital
12.2 Retail Pharmacy Stores

13 Global Injectable Drug Delivery Market – By End-User
13.1.1 Hospitals
13.1.2 Clinics
13.1.3 Home Care
13.1.4 Others

14 Global Injectable Drug Delivery Market – By Geography (Market Size – & million/billion)
14.1 Introduction
14.2 North America
14.2.1 US
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 U.K
14.3.2 Germany
14.3.3 Italy
14.3.4 France
14.3.5 Spain
14.3.6 Rest of Europe
14.4 Asia-Pacific
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 South Korea
14.4.5 Rest of APAC
14.5 Rest of the World
14.5.1 South America
14.5.2 Middle East
14.5.3 Africa

15 Global Injectable Drug Delivery Market – Entropy
15.1 New product launches
15.2 M&A’s, collaborations, JVs and partnerships

16 Global Injectable Drug Delivery Market Company Profile (Key Players)
16.1 Market Share, Company Revenue, Products, M&A, Developments
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Pfizer, Inc.
16.5 Genentech Inc.
16.6 Polymer Factory
16.7 Schott AG
16.8 Teva Pharmaceutical Industries Ltd.
16.9 Sandoz (A Division of Novartis AG)
16.10 Terumo Corporation
16.11 Presage Bioscience
16.12 Company 11 & more

17 Global Injectable Drug Delivery Market – Appendix
17.1 Sources
17.2 Abbreviations